passage bio stock forecast

Shares of Passage Bio stock opened at 177 on Thursday. PHILADELPHIA March 15 2022 GLOBE NEWSWIRE -- Passage Bio Inc.

Passage Bio Inc Investors And News Stock Information

Passage Bio intends to raise 125 million in an upcoming IPO.

. NASDAQPASG Get Rating Wedbush issued their FY2026 EPS estimates for Passage Bio in a research note. Greater flexibility precision for US small cap trading strategies. PASG stock quote history news and other vital information to help you with your stock trading and investing.

Smart Technology for Confident Trading. Passage Bio Inc a genetic medicines company develops transformative therapies for central nervous system diseases. Passage Bio NASDAQ.

Passage Bio Inc PASG shares closed today at 10 above its 52 week low of 630 giving the company a market cap of 346M. NASDAQPASG shares rose in value on Friday 051322 with the stock price up by 517 to the previous days close as strong demand from. Backed By 30 Years Of Experience.

2 days agoThe Goldman Sachs Group downgraded shares of Passage Bio from a buy rating to a neutral rating and lowered their price objective for the stock from 2900 to 600 in a report. Wall Street Stock Market Finance report prediction for the future. Ad Explore the Latest Features Tools to Become a More Strategic Trader.

According to the issued ratings of 6 analysts in the last year the consensus rating for Passage Bio stock is Buy based on the current 2 hold ratings and 4 buy ratings for PASG. Bruce Goldsmith Courtesy Passage Bio Passages stock jumped 20 on Friday its first day trading from 18 to nearly 22. See Passage Bio Inc.

Passage Bio Inc Stock Market info Recommendations. In total the offering brought in 216 million for the. Estimated cash runway extended into Q2 2024.

Buy or sell Passage Bio stock. A rare market phenomena could change everything and theres no telling when it will occur. Find real-time PASG - Passage Bio Inc stock quotes company profile news and forecasts from CNN Business.

Ad Invest Early in Emerging Technology Startups with the Highest Growth Potential. PASG stock analyst estimates including earnings and revenue EPS upgrades and downgrades. Now is the time to move.

As recession looms investors buy up the discounts. Passage Bio has a 52 week low of 157 and a 52 week high of 1614. Posted by MarketBeat News on Mar 8th 2022.

Youll find the Passage Bio. Learn How to Make Your Saving Goals a Reality. What is PASGs Earnings Per Share EPS forecast for 2022.

PASG a clinical-stage genetic medicines. Is a clinical stage genetic medicines company. PASG has filed to raise 125 million in an IPO of its common stock according to an S-1 registration statement.

The stock is currently down 750 year-to. The main clinical program involves PBGM01 which is being used to treat GM1 gangliosidosis and a phase 12. Please note that any opinions estimates or.

Their forecasts range from 600 to 3400. The businesss fifty day simple moving. Ad Same size as comparable ETF options but cash settled and European exercise.

Motley Fools Stock Advisor is now only 89year. This suggests a possible upside of 9000 from. Gain access to the best start-ups with maximum growth potential.

Ad Invest Early in Emerging Technology Startups with the Highest Growth Potential. Analyst estimates including PASG earnings per share estimates and analyst recommendations. The firm is developing.

Ad These 5 companies are set for historic price action. The 13 analysts offering price forecasts for Passage Bio have a median target of 2462 with a high estimate of 4500 and a low estimate. Find the latest Passage Bio Inc.

It develops PBGM01 which utilizes a. On average they expect Passage Bios share price to reach 2000 in the next year. The average PASSAGE BIO stock price prediction forecasts a potential upside of 9018 from the current PASG share price of 183.

What are analysts forecasts for Passage Bio stock. Passage Bio undertakes no obligation to publicly update any forward-looking statement whether written or oral that may be made from time to time whether as a result of. Find Out What Services a Dedicated Financial Advisor Offers.

Is followed by the analysts listed above. Gain access to the best start-ups with maximum growth potential. Ad Searching for Financial Security.

Ad Exclusive Offer for New Members. The average price target is 2060 with a high forecast of 3400 and a low forecast. Based on 6 Wall Street analysts offering 12 month price targets for Passage Bio in the last 3 months.

The Company is focused on developing transformative therapies for central nervous.

Best Performing Philadelphia Area Stocks Of 2021 Philadelphia Business Journal